World RNA Series

Upcoming Events in the World RNA Series

We have seen enormous strides in the developments and breakthroughs in RNA-based vaccines, RNA-based therapeutics and targeting RNA fields since the onset of the global pandemic. Keeping pace with the field's rapid advancements, the World RNA Series from Hanson Wade continues to provide unrivaled industry-focused events to help deliver safe and effective RNA therapies to patients faster.

Get a comprehensive overview of the upcoming events within the World RNA Series portfolio below. If you have any questions, get in touch at


July 11-13, 2023 | Boston, MA

Optimize RNA Editing Technology to Safely Deliver Novel Payloads, Enhance Potency & Durability to Achieve Clinical Validation in Patients Faster


July 26-28, 2023 | Boston, MA

Unlock mRNA Platforms for Next Generation Therapeutics & Vaccines from Concept to Clinical Validation & Commercialization for Patients in Need Across All Disease Indications


August 23-24, 2023 | Boston, MA

Successfully Develop Sensitive, Reproducible, High-Throughput Screening Tools & Assays to Optimize Hit Finding for Accelerated RNA-Targeted Drug Discovery


August 29-31, 2023 | Berlin, Germany

Confidently Improve mRNA Characterisation, Quality & Potency with Novel Analytical Tools for Efficient Approval & Commercial Release of Your mRNA Therapeutics & Vaccines


September 5-7, 2023 | Boston, MA

Unlock Native & Engineered Exosomes with Improved Targeting, Optimize Analytics & Achieve GMP Manufacturing for Effective Translation into the Clinic & Towards Commercialization

Untitled (200 × 50 px) (3)

September 26-28, 2023 | Boston, MA

Accelerating mRNA Process Development & Manufacturing from Research to Commercial Scale with Increased Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness


October 10-12, 2023 | Boston, MA

Improve Immunogenicity, Delivery & CMC of mRNA Cancer Vaccines Towards Accelerated Discovery, Translation & Clinical Development of Next Generation Cancer Treatments for Patients

RNA Targeted Drug Discovery Logo (002)

December 12-14,2023 | Boston, MA

Improve Rational Design, Specificity & Selectivity of Small Molecules Targeting RNA to Enable Safe & Effective Drugs to Accelerate into the Clinic

Returning 2024:

HW230316 3rd mRNA Based Therapeutics Summit Europe logo

Strengthen Safe & Effective mRNA Pipelines of Vaccines & Therapeutics by Improving Cell Specific Payload Expression, Durability & Immunogenicity towards Accelerated Development & Regulatory Approvals

Returning January 2024 | Berlin, Germany


3rd mRNA Analytical Development Summit logo FINAL With Tag

Pioneer Novel Analytical & Biological Assays & Tools to Robustly Characterize Safety, Consistency & Efficacy of Your mRNA Therapeutics & Vaccines for Accelerated Approval

Returning February 2024 | Boston, MA


mRNA-Based Therapeutics (1)

Accelerating Extrahepatic Delivery, CMC & Clinical Development of Targeted siRNA Therapeutics for Modular, Reproducible & Effective Gene Silencing Therapies Against Oncology, CNS, Rare Diseases & Beyond

Returning March 2024 | Boston, MA


mRNA Process EU - Landscape - Evvnt - 1000x400 (2)

Accelerating the End to End of mRNA Process Development & Manufacturing, From Research to Commercial Scale Maximizing Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness

Returning April 2024, Frankfurt, Germany


Next Gen RNA Therapeutics

Stay Ahead of the Curve with Novel RNA Therapeutics that Offer Exceptional Stability & Durability Whilst Addressing Key Delivery, Pharmacology & Scalability Challenges to Successfully Translate Safe & Effective Next Generation RNA Therapeutics into the Clinic

Returning May, 2024| Boston, MA


spex prospectus

Supporting Optimized Purity, Stability & Raw Material Testing for Vaccine Developers to Set Quality Standards at Scale & Avoid GMP Obstacles to Accelerate the Development & Release of Safe & Effective mRNA Medicines

Returning June, 2024 | Boston, MA